Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | pyruvate dehydrogenase kinase, isozyme 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | pyruvate dehydrogenase (lipoamide) kinase, putative | pyruvate dehydrogenase kinase, isozyme 2 | 343 aa | 321 aa | 22.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | phd finger protein, putative | 0.0034 | 0 | 0.5 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0041 | 0.0251 | 0.0437 |
Schistosoma mansoni | hypothetical protein | 0.0195 | 0.5745 | 0.5745 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0058 | 0.0875 | 1 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0144 | 0.3912 | 0.6809 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0047 | 0.0468 | 0.0814 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0069 | 0.1271 | 0.1271 |
Loa Loa (eye worm) | hypothetical protein | 0.0144 | 0.3912 | 0.3912 |
Toxoplasma gondii | pyruvate dehydrogenase kinase, putative | 0.005 | 0.0591 | 0.6754 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.0144 | 0.3912 | 0.6809 |
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.0144 | 0.3912 | 1 |
Trichomonas vaginalis | glutaminase, putative | 0.0315 | 1 | 0.5 |
Brugia malayi | jmjC domain containing protein | 0.0041 | 0.0251 | 0.0251 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0041 | 0.0251 | 0.0251 |
Echinococcus multilocularis | geminin | 0.0195 | 0.5745 | 1 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0041 | 0.0251 | 0.0251 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0041 | 0.0251 | 0.0437 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0144 | 0.3912 | 0.3912 |
Echinococcus granulosus | jumonji domain containing protein | 0.0047 | 0.0468 | 0.0814 |
Onchocerca volvulus | Alhambra homolog | 0.0034 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.0853 | 0.0853 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0136 | 0.3628 | 0.3628 |
Giardia lamblia | PHD finger protein 15 | 0.0034 | 0 | 0.5 |
Brugia malayi | jmjC domain containing protein | 0.011 | 0.2716 | 0.2716 |
Loa Loa (eye worm) | glutaminase 2 | 0.0315 | 1 | 1 |
Loa Loa (eye worm) | glutaminase | 0.0315 | 1 | 1 |
Brugia malayi | kinase, mitochondrial precursor | 0.0144 | 0.3912 | 0.3912 |
Schistosoma mansoni | jumonji domain containing protein | 0.0087 | 0.1913 | 0.1913 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.0144 | 0.3912 | 0.6809 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.0144 | 0.3912 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0034 | 0 | 0.5 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.011 | 0.2716 | 0.4728 |
Schistosoma mansoni | hypothetical protein | 0.0195 | 0.5745 | 0.5745 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0041 | 0.0251 | 0.0251 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.011 | 0.2716 | 0.4728 |
Schistosoma mansoni | glutaminase | 0.0315 | 1 | 1 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.0136 | 0.3628 | 0.3628 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.0144 | 0.3912 | 1 |
Echinococcus granulosus | geminin | 0.0195 | 0.5745 | 1 |
Mycobacterium ulcerans | glutaminase | 0.0315 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 10000 nM | BindingDB_Patents: Inhibition Assay. The inhibitory action of PDHK activity was indirectly evaluated by performing a kinase reaction in the presence of a test compound and measuring the residual PDH activity. For expression of hPDHK2 activity, Escherichia coli strain BL21(DE3) cells (Novagen) were transformed with the pET17b vector containing modified hPDHK2 cDNA. Escherichia coli were grown to an optical density 0.6 (600 nmol/L) at 30C. Protein expression was induced by the addition of 500 umol/L isopropyl-beta-thiogalactopyranoside. Escherichia coli were cultured at 30 C. for 5 hr and harvested by centrifugation. Resuspension of the Escherichia coli paste was disrupted by a microfluidizer. FLAG-Tagged protein was separated using FLAG affinity gel (Sigma). The gel was washed with 20 mmol/L N-(2-hydroxyethyl)piperazine-N'-2-ethanesulfonic acid-sodium hydroxide (HEPES-NaOH), 500 mmol/L sodium chloride, 1% ethylene glycol, and 0.1% Pluronic F-68 (pH 8.0), and the binding protein was eluted with 20 mmol/L HEPES. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.